CD163 impairs HBV clearance in mice by regulating intrahepatic T cell immune response via an IL-10-dependent mechanism
Abstract
Background & aims Chronic hepatitis B (CHB) arises from a persistent hepatitis B virus (HBV) infection, complicating efforts for a functional cure. Kupffer cells (KCs), liver-resident macrophages, are pivotal in mediating immune tolerance to HBV. Although CD163 marks M2-polarized KCs, its precise role in HBV infection remains unclear and warrants further investigation. Methods CD163 expression in liver tissues of patients with CHB was analyzed using the Gene Expression Omnibus (GEO) database. Cd163 knockout mice were utilized to establish HBV-persistent mouse model, and CD163 deficiency effect on HBV viral markers and T cell immune responses were examined in vivo and in vitro. Results CD163 expression was elevated and correlated with ALT levels in the liver of patients with CHB. In HBV-persistent mouse model, CD163 deficiency facilitated the clearance of HBsAg, HBeAg, HBV DNA, and HBcAg. Additionally, CD163 deficiency promoted the differentiation of naïve T cells into HBV-specific effector T cells. Further, we found that CD163 deficiency reduces KCs-derived IL-10 secretion, and blocking IL-10 further strengthens the enhanced HBV-specific T cell response due to CD163 deficiency. Conclusions Our findings indicate that CD163 deficiency enhances the HBV-specific T cell response, thereby facilitating HBV clearance through reducing KCs-derived IL-10 secretion. This suggests that CD163 may serve as a potential target for the restoration of exhausted T cell function.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In chronic viral hepatitis or parasitic infections, excessive anti-inflammatory polarization may impair pathogen clearance and perpetuate chronic inflammation.
“In these settings, excessive anti-inflammatory polarization may impair pathogen clearance and perpetuate chronic inflammation, thereby reshaping macrophage function (129–135).”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [130]
Cites
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 4,525 · see citing works
Targeting hepatic macrophages to treat liver diseases
Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.026 · Cited by 1,003 · see citing works
Interleukin-10 determines viral clearance or persistence in vivo
Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B., & Oldstone, M. B. A. (2006) · Nature Medicine · doi:10.1038/nm1492 · Cited by 920 · see citing works
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920 · see citing works
Wei, C., Yang, C., Wang, S., Shi, D., Zhang, C., Lin, X., Liu, Q., Dou, R., & Xiong, B. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0976-4 · Cited by 833 · see citing works
Genomic analysis of the host response to hepatitis B virus infection
Wieland, S. F., Thimme, R., Purcell, R. H., & Chisari, F. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401771101 · Cited by 651 · see citing works
CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens
Helmy, K. Y., Katschke, K. J., Gorgani, N. N., Kljavin, N. M., Elliott, J. M., Diehl, L. J., Scales, S. J., Ghilardi, N., & Campagne, M. V. L. (2006) · Cell · doi:10.1016/j.cell.2005.12.039 · Cited by 629 · see citing works
Baessler, A., & Vignali, D. A. A. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090222-110914 · Cited by 420 · see citing works
Immune responses and immunopathology in acute and chronic viral hepatitis
Shin, E., Sung, P. S., & Park, S. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.69 · Cited by 362 · see citing works
The Many Alternative Faces of Macrophage Activation
Hume, D. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00370 · Cited by 303 · see citing works
An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection
Huang, L.-R., Wu, H.-L., Chen, P.-J., & Chen, D.-S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608578103 · Cited by 294 · see citing works
Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases
Skytthe, M. K., Graversen, J. H., & Moestrup, S. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155497 · Cited by 264 · see citing works
Etzerodt, A., Tsalkitzi, K., Maniecki, M. B., Damsky, W., Delfini, M., Baudoin, E., Moulin, M., Bosenberg, M., Graversen, J. H., Auphan‐Anezin, N., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20182124 · Cited by 231 · see citing works
Bility, M. T., Cheng, L., Zhang, Z., Luan, Y., Li, F., Chi, L., Zhang, L., Tu, Z., Gao, Y., Fu, Y., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004032 · Cited by 227 · see citing works
MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure
Triantafyllou, E., Pop, O. T., Possamai, L. A., Wilhelm, A., Liaskou, E., Singanayagam, A., Bernsmeier, C., Khamri, W., Petts, G., Dargue, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313615 · Cited by 226 · see citing works
Rivino, L., Bert, N. L., Gill, U. S., Kunasegaran, K., Cheng, Y., Tan, D., Becht, É., Hansi, N. K., Foster, G. R., Su, T., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci92812 · Cited by 208 · see citing works
Mechanisms of Hepatitis B Virus Persistence
Tsai, K.-N., Kuo, C.-F., & Ou, J. J. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.07.006 · Cited by 199 · see citing works
Bert, N. L., Gill, U. S., Hong, M. L. W., Kunasegaran, K., Tan, D., Ahmad, R., Cheng, Y., Dutertre, C., Heinecke, A., Rivino, L., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.019 · Cited by 192 · see citing works
Tian, Y., Kuo, C.-F., Akbari, O., & Ou, J. J. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.008 · Cited by 176 · see citing works
The scientific basis of combination therapy for chronic hepatitis B functional cure
Lim, S. G., Baumert, T. F., Boni, C., Gane, E. J., Levrero, M., Lok, A. S.-F., Maini, M. K., Terrault, N. A., & Zoulim, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00724-5 · Cited by 176 · see citing works
Kazankov, K., Francisco Barrera, M., Møller, H. J., Bibby, B. M., Vilstrup, H., George, J., & Grønbæk, H. (2014) · Hepatology · doi:10.1002/hep.27129 · Cited by 172 · see citing works
Tout, I., Loureiro, D., Mansouri, A., Soumelis, V., Boyer, N., & Asselah, T. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.013 · Cited by 166 · see citing works
Simone, G. D., Andreata, F., Blériot, C., Fumagalli, V., Laura, C., Garcia-Manteiga, J., Lucia, P. D., Gilotto, S., Ficht, X., Ponti, F. F. D., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.05.005 · Cited by 139 · see citing works
Heterogeneity and Function of Kupffer Cells in Liver Injury
Li, W., Chang, N., & Li, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940867 · Cited by 102 · see citing works
Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection
Faure‐Dupuy, S., Delphin, M., Aillot, L., Dimier, L., Lebossé, F., Fresquet, J., Parent, R., Matter, M. S., Rivoire, M. L., Bendriss‐Vermare, N., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.032 · Cited by 102 · see citing works
Xu, L., Yin, W., Sun, R., Wei, H., & Tian, Z. (2014) · Hepatology · doi:10.1002/hep.26668 · Cited by 100 · see citing works
Aliabadi, E., Urbanek‐Quaing, M., Maasoumy, B., Bremer, B., Graßhoff, M., Li, Y., Niehaus, C., Wedemeyer, H. H., Kraft, A. R. M., & Cornberg, M. (2021) · Gut · doi:10.1136/gutjnl-2021-324646 · Cited by 99 · see citing works
Xiao, H., Du, X., Tao, Z., Jing, N., Bao, S., Gao, W., Dong, B., & Fang, Y. (2023) · Advanced Science · doi:10.1002/advs.202303894 · Cited by 78 · see citing works
Isolation of Mouse Intrahepatic Lymphocytes
Crispe, I. N. (1997) · Current Protocols in Immunology · doi:10.1002/0471142735.im0321s22 · Cited by 52 · see citing works
Liu, H., Li, F., Zhang, X., Yu, J., Wang, J., Jia, J., Yu, X., Shen, Z., Yuan, Z., Zhang, X., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix683 · Cited by 43 · see citing works
Self-citationLiver macrophages: Friend or foe during hepatitis B infection?
Faure‐Dupuy, S., Durantel, D., & Lucifora, J. (2018) · Liver International · doi:10.1111/liv.13884 · Cited by 40 · see citing works
Wu, L., Peng, W., Wu, H., Miaw, S., Yeh, S., Yang, H., Liao, P.-H., Lin, J., Chen, Y., Hong, Y., et al. (2019) · Hepatology · doi:10.1002/hep.30510 · Cited by 39 · see citing works
Mouse CD163 deficiency strongly enhances experimental collagen-induced arthritis
Svendsen, P., Etzerodt, A., Deleuran, B. W., & Moestrup, S. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-69018-7 · Cited by 39 · see citing works
Xiong, S., Zhu, D. Y., Liang, B., Li, M., Pan, W., He, J., Wang, H., Sutter, K., Dittmer, U., Lu, M., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103464 · Cited by 32 · see citing works
Recent advances in understanding T cell activation and exhaustion during HBV infection
Wang, L., Zeng, X.-Q., Wang, Z., Fang, L.-C., & Liu, J. (2023) · Virologica Sinica · doi:10.1016/j.virs.2023.10.007 · Cited by 30 · see citing works
Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure
Ye, H. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i18.2818 · Cited by 27 · see citing works
The clinical utility of CD163 in viral diseases
Yap, Y.-J., Wong, P., AbuBakar, S., Sam, S., Shunmugarajoo, A., Soh, Y. H., Misbah, S., & Rahman, A. K. A. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117243 · Cited by 23 · see citing works
Soluble CD163 Identifies Those at Risk for Increased Hepatic Inflammation & Fibrosis
Sherman, K. E., Meeds, H. L., Rouster, S. D., Abdel-hameed, E. A., Hernández, J., Tamargo, J. A., Chen, J., Ehman, R. L., & Baum, M. K. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab203 · Cited by 21 · see citing works
Fujiwara, Y., Ohnishi, K., Horlad, H., Saito, Y., Shiraishi, D., Takeya, H., Yoshii, D., Kaieda, S., Hoshino, T., & Komohara, Y. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1162 · Cited by 15 · see citing works
Pang, J., Zhang, G., Lin, Y., Xie, Z., Liu, H., Tang, L., Lu, M., Yan, R., Guo, H., Sun, J., et al. (2017) · Scientific Reports · doi:10.1038/srep39901 · Cited by 15 · see citing works
Self-citationXie, P., Yao, B., Huang, D., Chen, Y., Gong, Q., & Zhang, X. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00496 · Cited by 9 · see citing works
Self-citationXie, T., Fu, D.-J., Li, Z., Lv, D., Song, X., Yu, Y., Wang, C., Li, K., Zhai, B., Wu, J., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01881-0 · Cited by 8 · see citing works
Flagged first, then by citations
3 of the 45 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Liver Macrophages in the Pathogenesis of Viral Hepatitis
Tsomidis, I., Tsakou, A., Voumvouraki, A., & Kouroumalis, E. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48070687 · Cited by 2 · see citing works
Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages
Aquino, J. B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1792423 · Cited by 1 · see citing works
Kupffer cells are central to mitigating intravascular infections
Oliveira, F. R. M. B., & Kubes, P. (2025) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001128
Loftis, J. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29090-9.00006-4
The acetylation status and metabolic characterization of the HBV-induced macrophages
Zihao, S., Shaoke, W., Luo, Y., Ting, S., Yuerong, X., & Jiaxin, B. (2026) · Journal of Proteomics · doi:10.1016/j.jprot.2026.105626
Wang, F., Wang, L., Xu, Z. Y., 欧泽群, Yun, W., Haiying, Y., Fei, J., Song, J. H., Chen, Y., & Lv, K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1899891
Wang, L. (2026) · Journal of Immunology Research · doi:10.1155/jimr/6923534
- Authors
- Liu, Z., Li, G., Li, X., Wang, Y., Liao, L., Yang, T., Han, C., Huang, K., Chen, C., Li, X., Liu, H., & Zhang, X.
- Affiliations
- Nanfang Hospital (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- Corresponding author
- Liu, Ziying
- Liu, Hongyan
- Zhang, Xiaoyong
- Venue
- Antiviral Research
- Publisher
- Elsevier BV
- Published
- 2025-03
- Volume
- 235
- Pages
- 106093
- ISSN
- 0166-3542 (ISSN-L)
- OpenAlex
- W4406714590
- Cited by
- 7
- References
- 45
- Citations by year
- 2026: 5 · 2025: 2
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Antiviral Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Special Project for Research and Development in Key Areas of Guangdong Province
- Topics
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Keywords
- CD163, hepatitis B virus, chronic hepatitis B, Kupffer cells, M2 macrophage polarization, IL-10, HBV-specific T cell responses, T cell exhaustion, HBV clearance, persistent HBV infection, hepatic macrophages
- MeSH terms
- CD163 Antigen, Animals, Disease Models, Animal, Female, Hepatitis B Surface Antigens, Hepatitis B virus, Humans, Kupffer Cells, Liver, Male, Mice, Inbred C57BL, Receptors, Cell Surface, T-Lymphocytes, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Interleukin-10, Mice, Knockout, Hepatitis B, Chronic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review